资讯

Sanofi flunks mid-stage trial for asthma drug
Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...
Enhertu: Drug approved in the UK for advanced cancers. Here's what you need to know
A new cancer drug called trastuzumab deruxtecan, also known as Enhertu, has just been approved in the UK. This drug is ...